Bigtincan Holdings Logs AU$30 Million Revenue in Fiscal Q3; Shares Surge 19%

BTH

AU000000BTH6

Delayed Australian S.E. Other stock markets 08:27:41 2024-06-27 pm EDT			5-day change	1st Jan Change
0.105 ^AUD	+5.00%		-4.55%	-47.50%

Jun. 20	Bigtincan Holdings Rejects Vector's Revised Acquisition Offer	MT
Jun. 12	US Inflation, Policy Announcement Jitters Suppress Appetite for Australian Shares	MT

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about BIGN HLDG

Bigtincan Holdings Rejects Vector's Revised Acquisition Offer	Jun. 19	MT
US Inflation, Policy Announcement Jitters Suppress Appetite for Australian Shares	Jun. 12	MT
Bigtincan Holdings Says Non-Binding Indicative Offer from Vector Capital Withdrawn; Shares Down 18%	Jun. 11	MT
Vector Capital Management, L.P. cancelled the acquisition of Bigtincan Holdings Limited.	Jun. 11	CI
Bigtincan Holdings Receives AU$0.25 Per Share Acquisition Offer from Vector Capital Management	Jun. 11	MT
Vector Capital Management, L.P. made an offer to acquire Bigtincan Holdings Limited for AUD 150 million.	Jun. 10	CI
Bigtincan Holdings Limited Announces Executive Changes	Jun. 02	CI
Bigtincan Holdings Logs AU$30 Million Revenue in Fiscal Q3; Shares Surge 19%	Apr. 10	MT
Bigtincan Holdings Limited(ASX:BTH) dropped from S&P/ASX All Ordinaries Index	Mar. 17	CI
Bigtincan Shares Shed 11% as Fiscal H1 Revenue Contracts 1.5%; Loss Narrows	Feb. 27	MT
Transcript : Bigtincan Holdings Limited, H1 2024 Earnings Call, Feb 27, 2024	Feb. 27
Bigtincan Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 27	CI
Transcript : Bigtincan Holdings Limited - Shareholder/Analyst Call	Nov. 28
Bigtincan Holdings Limited Provides Earnings Guidance for the Fiscal Year 2024	Nov. 14	CI
Bigtincan Holdings Limited Announces Resignation of Farouk Hussein as Non-Executive Director	23-10-02	CI
Bigtincan Holdings Limited(ASX:BTH) dropped from S&P Global BMI Index	23-09-18	CI
Bigtincan Reportedly Say It Remains in Takeover Talks	23-09-17	CI
Bigtincan Holdings Launches Cost Reduction Program	23-09-15	MT
Transcript : Bigtincan Holdings Limited, 2023 Earnings Call, Aug 30, 2023	23-08-30
Bigtincan Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30	CI
Bigtincan to Borrow AU$15 Million to Grow AI Technology	23-07-21	MT
Bigtincan Holdings Limited Provides Financial Results Outlook for Fiscal Year 2023	23-07-20	CI
Transcript : Bigtincan Holdings Limited - Special Call	23-05-21
Bigtincan Holdings Limited Launches GenieAI Technology, Delivering Transformational Sales Productivity Gains to Customers	23-03-12	CI
Bigtincan Holdings Limited Provides Earnings Guidance for the Year 2023	23-03-12	CI

Beta Pharmaceutical Limited is a Australia-based biopharmaceutical company. The Company is focused on the identification, development and commercialization of products and therapies targeting the chemoprevention and treatment of breast cancer. The Company is working in collaboration with scientists at the College of Pharmacy, University of Louisiana at Monroe in southern the United States of America (ULM) to develop cancer chemopreventive agents using natural phytonutrients, called tocotrienols as treatments for breast cancers. Funded by Beta Pharmaceutical Limited, the applied research programme with ULM includes four laboratories and is known as the Breast Cancer and Health Project, which has been underway.

Sector

More about the company